Literature DB >> 16904237

Differential processing of pro-neurotensin/neuromedin N and relationship to pro-hormone convertases.

Patrick Kitabgi1.   

Abstract

Neurotensin (NT) is synthesized as part of a larger precursor that also contains neuromedin N (NN), a six amino acid neurotensin-like peptide. NT and NN are located in the C-terminal region of the precursor (pro-NT/NN) where they are flanked and separated by three Lys-Arg sequences. A fourth dibasic sequence is present in the middle of the precursor. Dibasics are the consensus sites recognized and cleaved by endoproteases that belong to the recently identified family of pro-protein convertases (PCs). In tissues that express pro-NT/NN, the three C-terminal Lys-Arg sites are differentially processed, whereas the middle dibasic is poorly cleaved. Pro-NT/NN processing gives rise mainly to NT and NN in the brain, to NT and a large peptide ending with the NN sequence at its C-terminus (large NN) in the gut and to NT, large NN and a large peptide ending with the NT sequence (large NT) in the adrenals. Recent evidence indicates that PC1, PC2 and PC5-A are the pro-hormone convertases responsible for the processing patterns observed in the gut, brain and adrenals, respectively. As NT, NN, large NT and large NN are all endowed with biological activity, the evidence reviewed here supports the idea that post-translational processing of pro-NT/NN in tissues may generate biological diversity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904237     DOI: 10.1016/j.peptides.2006.03.038

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

2.  Characterization of the prohormone complement in cattle using genomic libraries and cleavage prediction approaches.

Authors:  Bruce R Southey; Sandra L Rodriguez-Zas; Jonathan V Sweedler
Journal:  BMC Genomics       Date:  2009-05-16       Impact factor: 3.969

3.  Neurotensin and its receptors in the control of glucose homeostasis.

Authors:  Jean Mazella; Sophie Béraud-Dufour; Christelle Devader; Fabienne Massa; Thierry Coppola
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-26       Impact factor: 5.555

4.  Endogenous CNS expression of neurotensin and neurotensin receptors is altered during the postpartum period in outbred mice.

Authors:  Terri M Driessen; Changjiu Zhao; Anna Whittlinger; Horecia Williams; Stephen C Gammie
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

5.  Alterations in expression of endometrial genes coding for proteins secreted into the uterine lumen during conceptus elongation in cattle.

Authors:  Niamh Forde; Jai P Mehta; Paul A McGettigan; Solomon Mamo; Fuller W Bazer; Thomas E Spencer; Pat Lonergan
Journal:  BMC Genomics       Date:  2013-05-10       Impact factor: 3.969

6.  Origin and functional diversification of an amphibian defense peptide arsenal.

Authors:  Kim Roelants; Bryan G Fry; Lumeng Ye; Benoit Stijlemans; Lea Brys; Philippe Kok; Elke Clynen; Liliane Schoofs; Pierre Cornelis; Franky Bossuyt
Journal:  PLoS Genet       Date:  2013-08-01       Impact factor: 5.917

7.  The anti-apoptotic role of neurotensin.

Authors:  Christelle Devader; Sophie Béraud-Dufour; Thierry Coppola; Jean Mazella
Journal:  Cells       Date:  2013-03-04       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.